首页 正文

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

{{output}}
Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy with poor clinical outcomes. Ubiquitin-conjugating enzyme E2 D1 (UBE2D1), a key component of the ubiquitination machinery, has been implicated ... ...